Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

Scientists used high-resolution 3D X-ray imaging to uncover major structural and immune changes in the gut of Alzheimer's ...

The Women Health Belly Patch market is poised for substantial growth over the next decade, driven by increasing awareness of menstrual health ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

Anavex Life Sciences’ Anavex 2-73 to treat neurodegenerative disorders receives US patent: New York Tuesday, January 28, 2025, 17:00 Hrs [IST] Anavex Life Sciences Corp., a clin ...

Anavex’s newest patent will be expected to remain in force at least until July 2039, not including any patent term extensions. It will expand and supplement the current ANAVEX®2-73 (blarcamesine) ...

Here are a few of the top charities tackling Alzheimer’s disease. These organizations fund research, raise awareness, educate, and provide comfort to those living with and caring for those with ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

have made headline news as the UK’s first-ever approved drugs for treating early-stage Alzheimer’s disease, although they’re not available on the NHS. Richard Oakley, Associate Director of Research ...

Learn More Prevention of Alzheimer’s Disease Is there a cure for Alzheimer's disease? There is no cure yet for Alzheimer's disease, though there are strategies and medications that can keep symptoms ...